Bioequivalence and Bioavailability Forum

BioBridges 2023 Helmut 2023-04-06 10:52 [Conferences / Workshops]📌

Requesting data for a publication 📥 ♻️ 🚀 Helmut 2021-04-08 17:09 [General Statistics]📌
- Requesting data for a presentation Helmut 2023-02-23 10:46

⚠️ Read before registering Helmut 2016-04-14 23:39 [Tips / Tricks]📌

Reference-Scaled Average Bioequivalence Brus 2023-06-06 12:18 [RSABE / ABEL]

Switchability with replicate design studies Achievwin 2022-05-20 04:44 [Design Issues]
- Switchability = IBE Helmut 2022-05-20 09:17
  - Switchability = IBE Achievwin 2022-05-20 14:19
    - S × F interaction Helmut 2022-05-20 15:33
      - S × F interaction Achievwin 2022-05-20 23:32
      - S × F interaction Brus 2023-06-06 11:02

Sample size estimation for parallel design with more than 2 treatments BEQool 2023-05-24 21:05 [Power / Sample Size]
- Sample size estimation for parallel design with more than 2 treatments dshah 2023-05-25 09:42
- >2 treatments, multiplicity or not Helmut 2023-05-27 08:26
  - >2 treatments, multiplicity or not BEQool 2023-05-29 10:41

ICH E6(R3) draft Guideline reaches Step 2 of the ICH process SMA 2023-05-24 08:37 [BE/BA News]
- Validation of sample size estimations? Helmut 2023-05-29 08:34

Washout based on mean ± SD of t½ Imph 2022-09-25 13:52 [Design Issues]
- Washout based on mean ± SD of t½ Helmut 2022-09-25 16:08
  - Washout based on mean ± SD of t½ Imph 2022-09-26 15:24
    - Washout based on mean ± SD of t½ Shuanghe 2022-09-26 17:34
    - Washout based on mean ± SD of t½ Helmut 2022-09-26 17:35
    - If you have data… Helmut 2022-09-27 11:52
      - If you have data… Imph 2022-10-25 09:21
  - Washout based on mean ± SD of t½ Imph 2023-05-26 23:31
    - Washout based on mean ± SD of t½ Helmut 2023-05-27 06:52
      - Washout based on mean ± SD of t½ Imph 2023-05-27 08:36

Sample Size Benefits of Replicate Design with ABE Sereng 2023-05-24 15:41 [Power / Sample Size]
- Sample Size Benefits of Replicate Design with ABE dshah 2023-05-25 09:56
- Dropouts less problematic Helmut 2023-05-25 16:27

Data analysis and sample size for replicate study designs as per recent FDA guidance balakotu 2023-05-23 12:16 [Regulatives / Guidelines]

regulatory guideline wock 2023-05-22 06:06 [Regulatives / Guidelines]

Sexy… Helmut 2023-05-19 20:32 [Off Topic]
- Apotex vs MSN mittyri 2023-05-20 20:38

FDA’s mixed model for ABE: another round Helmut 2019-08-19 13:07 [🇷 for BE/BA]
- emmeans for lme when the data is incomplete mittyri 2023-05-20 20:19

Design for the EMA ryraman2661 2023-05-15 13:03 [Regulatives / Guidelines]
- BE for the EMA Helmut 2023-05-15 13:40
  - BE for the EMA ryraman2661 2023-05-16 08:04
  - BE for the EMA Ohlbe 2023-05-16 08:51

R Validation Imph 2023-05-14 13:48 [Power / Sample Size]
- R Validation Helmut 2023-05-15 11:54
  - R Validation Imph 2023-05-15 13:35
    - R Validation Helmut 2023-05-15 13:42

Admin contact
22,618 posts in 4,741 threads, 1,612 registered users;
23 visitors (0 registered, 23 guests [including 8 identified bots]).
Forum time: 22:14 CEST (Europe/Vienna)

There are in fact two things, science and opinion;
the former begets knowledge, the latter ignorance. Hippocrates

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz